Recent studies have discovered a subset of miRNAs that can convert the immunosuppressive tumor microenvironment into a pro-inflammatory state by downregulating PD-L1 expression and modifying oncogenic signaling pathways in TNBC cells. The gene discussed is CD274; the disease is neoplasm.